⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHC News
Bausch Health Companies Inc
Bausch Health Announces Third Quarter 2025 Results
accessnewswire.com
BHC
BHC
Bausch Health Announces Results of Special Meeting of Shareholders
accessnewswire.com
BHC
BHC
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
accessnewswire.com
BHC
BHC
Bausch Health to Announce Third Quarter 2025 Results on October 29
accessnewswire.com
BHC
BHC
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
accessnewswire.com
BHC
BHC
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
prnewswire.com
BHC
BHC
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
accessnewswire.com
BHC
BHC
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
accessnewswire.com
BHC
BHC
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
accessnewswire.com
BHC
DRRX
BHC
DRRX
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
accessnewswire.com
BHC
BHC